Applied Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Applied Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2019 to Q2 2024.
  • Applied Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -170 %, a 2.12% increase year-over-year.
  • Applied Therapeutics, Inc. annual Return On Assets for 2023 was -276 %, a 99.1% decline from 2022.
  • Applied Therapeutics, Inc. annual Return On Assets for 2022 was -139 %, a 64.6% decline from 2021.
  • Applied Therapeutics, Inc. annual Return On Assets for 2021 was -84.2 %, a 22.3% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -170 +3.68 +2.12% Apr 1, 2024 Jun 30, 2024
Q1 2024 -263 -126 -91.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -276 -137 -99.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -246 -114 -86.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -174 -54.7 -46% Apr 1, 2023 Jun 30, 2023
Q1 2023 -137 -35 -34.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -139 -54.4 -64.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -132 -52.4 -66.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -119 -39.7 -50.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -102 -23 -29.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -84.2 -15.3 -22.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -79.1 -7.32 -10.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -79.3 -10.9 -15.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -78.9 -13 -19.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -68.9 +53.1 +43.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -71.8 +42.4 +37.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -68.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -65.9 Jan 1, 2020 Mar 31, 2020
Q4 2019 -122 Oct 1, 2019 Dec 31, 2019
Q3 2019 -114 Jul 1, 2019 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.